Endorsements - MPP
GSK tops pharma access to medicines table - PMLiVE
Access to medicine company ranking developing countries 2022 | Statista
Access to Medicines Index 2022: AstraZeneca on patent transparency
Access to medicine index 2022 (ATMI)
2022 Access to Medicine Index | Access to Medicine Foundation
Company profiles & report cards | Access to Medicine Foundation
Access to Medicine Index: Critical tool for investors – Seventh Generation Interfaith Coalition for Responsible Investing
Access to Medicine Index 2021 - The challenge for pharma companies: become a catalyst not a barrier
Advancing equitable access to care
New 2024 Index Methodology places greater focus on measuring patient reach | Access to Medicine Foundation
How Johnson & Johnson Works to Improve Global Access to Medicines
Access to Medicine | Merck
Report finds Big Pharma is doing more for acc | EurekAlert!
J&J Innovative Medicine on X: "We ranked No. 2 on the 2022 Access to Medicines Index, moving up one spot from 2021. For 6 years, we've ranked in the top 3 as
List of countries included in the 2020 Access to Medicine Index -106... | Download Scientific Diagram
Access to Medicine Index | Janssen EMEA
COVID-19 showcases medicine access issues in low-income nations at 'warp speed' | S&P Global Market Intelligence
Access to Medicine Index Report | Astellas Pharma Inc.
Merck is No 4 in the Access to Medicine Index
Access to Medicine Index 2016: Pharmaunternehmen verbessern ihre Strategien, um Arme zu erreichen – doch der Ausbau ist schleichend | Access to Medicine Foundation
The Access to Medicine Index Finds That a Handful of Pharmaceutical Companies are Developing the Bulk of Urgently Needed New Medicines for the Poor
Handful of pharma companies developing urgently needed new medicines for poor: The Access to Medicine Index - Express Pharma
Access to Medicines Foundation - Gaffi | Gaffi - Global Action For Fungal Infections
Index finds more pharma companies moving to address access to medicine. Will they now go further? | Access to Medicine Foundation
GSK auf Platz 1 im Access-to-Medicine-Index 2018 - Leitbetriebe Austria
Access to Medicines Index 2022: AstraZeneca on patent transparency
